Evidence mapPaperPMID 8601640Full record

Trial reportThe Journal of clinical investigation1996

Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography.

P Nuutila, M Raitakari, H Laine, O Kirvelä, T Takala, T Utriainen, S Mäkimattila, O P Pitkänen, U Ruotsalainen, H Iida and 2 more

Open access · bronzeAbstract readClinical TrialControlled Clinical Trial
In one paragraph

Trial report in The Journal of clinical investigation, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 158 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Organ-Specific Perfusion Response to Adenosine as Measured Using Total-Body PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  10. Radiopharmaceuticals for Skeletal Muscle PET Imaging.International journal of molecular sciences · 2024
    Review
  11. Total-Body Perfusion Imaging with [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Large-Scale Production ofACS central science · 2019
    Article
  17. Article
  18. Review
  19. Muscle microvasculature's structural and functional specializations facilitate muscle metabolism.American journal of physiology. Endocrinology and metabolism · 2016
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

P NuutilaTurku Medical Cyclotron/PET Center, University of Turku, Finland.
M Raitakari
H Laine
O Kirvelä
T Takala
T Utriainen
S Mäkimattila
O P Pitkänen
U Ruotsalainen
H Iida
J Knuuti
H Yki-Järvinen
Research Institute for Brain and Blood Vessels Akita · JPUniversity of Helsinki · FIUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Defects in insulin stimulation of blood flow have been used suggested to contribute to insulin resistance. To directly test whether glucose uptake can be altered by changing blood flow, we infused bradykinin (27 microgram over 100 min), an endothelium-dependent vasodilator, into the femoral artery of 12 normal subjects (age 25+/-1 yr, body mass index 22+/-1 kg/m2) after an overnight fast (n = 5) and during normoglycemic hyperinsulinemic (n = 7) conditions (serum insulin 465+/-11 pmol/liter, 0-100 min). Blood flow was measured simultaneously in both femoral regions using [15O]-labeled water ([15O]H2O) and positron emission tomography (PET), before and during (50 min) the bradykinin infusion. Glucose uptake was measured immediately after the blood flow measurement simultaneously in both femoral regions using [18F]-fluoro-deoxy-glucose ([18F]FDG) and PET. During hyperinsulinemia, muscle blood flow was 58% higher in the bradykinin-infused (38+/-9 ml/kg muscle x min) than in the control leg (24+/-5, P<0.01). Femoral muscle glucose uptake was identical in both legs (60.6+/-9.5 vs. 58.7+/-9.0 micromol/kg x min, bradykinin-infused vs control leg, NS). Glucose extraction by skeletal muscle was 44% higher in the control (2.6+/-0.2 mmol/liter) than the bradykinin-infused leg (1.8+/-0.2 mmol/liter, P<0.01). When bradykinin was infused in the basal state, flow was 98% higher in the bradykinin-infused (58+/-12 ml/kg muscle x min) than the control leg (28+/-6 ml/kg muscle x min, P<0.01) but rates of muscle glucose uptake were identical in both legs (10.1+/-0.9 vs. 10.6+/-0.8 micromol/kg x min). We conclude that bradykinin increases skeletal muscle blood flow but not muscle glucose uptake in vivo. These data provide direct evidence against the hypothesis that blood flow is an independent regulator of insulin-stimulated glucose uptake in humans.

Indexed as

AdultBiological Transport, ActiveBradykininDeoxyglucoseFluorine RadioisotopesFluorodeoxyglucose F18GlucoseHemodynamicsHumansInsulinInsulin ResistanceMaleMuscle, SkeletalOxygen RadioisotopesTomography, Emission-ComputedVasodilationBradykininDeoxyglucoseFluorine RadioisotopesFluorodeoxyglucose F18GlucoseInsulinOxygen Radioisotopes

Identifiers

PMID8601640
PMCPMC507239
OpenAlexW2010206177

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.